STOCK TITAN

elf Beauty (ELF) Financials

ELF
Trailing 12 months to June 30, 2026
Revenue $1.8B +31.2% YoY
Net Income $59.6M -39.1% YoY
EPS (Diluted) $1.00 -41.2% YoY
Free Cash Flow $280.2M +107.6% YoY
Market Cap $6.2B as of Sep 2, 2026
Price / Sales 3.5x on $1.8B revenue, trailing 12 months to June 30, 2026
Price / Earnings 104x on $59.6M net income, trailing 12 months to June 30, 2026
Price / Book 5.3x on $1.2B equity, Q1 FY2027

A multiple compares the market's price with a filed figure; it says what the market pays, not how the business is doing. The market capitalization is the vendor's as of Sep 2, 2026; every other figure is from the SEC filings on this page. Not financial advice.

Source SEC Filings (10-K/10-Q) Latest period Q1 FY2027, ended Jun 30, 2026 Reported Currency USD FYE March

Newest figures come from the 10-Q for Q1 FY2027, filed Aug 6, 2026. Each column of the statement tables below links to the filing it was taken from, and every filing is listed on the ELF SEC filings page.

elf Beauty (ELF) reported $1.8B in revenue over the twelve months to Jun 30, 2026, up 31.2% from the prior twelve months. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 12 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Rhea AI ELF FY2026

Revenue scale continued, but heavier investment and overhead converted stable gross margins into sharply lower operating returns.

FY2026 net margin was 1.6% while free cash flow margin reached 11.6%, a wide divergence between accounting profit and cash generation. That gap indicates that non-cash charges and working-capital movements materially supported cash flow even as reported earnings weakened.

The capital base expanded faster than sales: total assets increased from $1.2B in FY2025 to $2.4B in FY2026. Goodwill climbed from $340.6M to $853.5M, consistent with a major investment or transaction rather than routine working-capital needs. Debt-to-equity rose from 0.3x to 0.7x, so financing now plays a larger role in the operating structure.

Revenue increased 24.6% in FY2026, yet operating income declined 53.4%; scale did not translate into operating leverage. With gross margin holding at 70.7%, the deterioration is concentrated after product costs, while SG&A rose from $777.7M to $1.0B.

[ NOT FINANCIAL ADVICE ]

Financial Health Signals

Profitability Growth Leverage Liquidity CashFlow Returns 61 / 100
Financial Health Score 61/100

Scored against operating companies for FY2026. Each of the six dimensions is a percentile rank within that peer group; the overall is their average, with missing dimensions counted as zero out of six. A high score means strong standing among peers, not absolute cross-industry strength. How this score is calculated →

Health score ≠ stock price. This rates the quality of elf Beauty's business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.

Profitability
66

elf Beauty has an operating margin of 4.5%, meaning the company retains $5 of operating profit per $100 of revenue. This strong profitability earns a score of 66/100, reflecting efficient cost management and pricing power. This is down from 12.0% the prior year.

Growth
87

elf Beauty's revenue surged 24.6% year-over-year to $1.6B, reflecting rapid business expansion. This strong growth earns a score of 87/100.

Leverage
18

elf Beauty has elevated debt relative to equity (D/E of 0.72), meaning the company relies heavily on borrowed funds. This high leverage results in a low score of 18/100, reflecting increased financial risk.

Liquidity
66

With a current ratio of 2.35, elf Beauty holds $2.35 in current assets for every $1 of short-term obligations. This comfortable liquidity earns a score of 66/100.

Cash Flow
66

elf Beauty converts 11.6% of revenue into free cash flow ($190.1M). This strong cash generation earns a score of 66/100.

Returns
64

elf Beauty's ROE of 2.3% shows moderate profitability relative to equity, earning a score of 64/100. This is down from 14.7% the prior year.

Altman Z-Score Safe
3.88

elf Beauty scores 3.88, well above the 2.99 safe threshold. The score is driven primarily by a large market capitalization ($6.2B) relative to total liabilities ($1.3B). This indicates low bankruptcy risk based on profitability, leverage, and asset efficiency.

Distress-screening estimate for non-financial companies. Not computed for banks or insurers, where the Altman model does not apply.

Piotroski F-Score Weak
3/9

elf Beauty passes 3 of 9 financial strength tests. 3 of 4 profitability signals pass, no leverage/liquidity signals pass (rising debt, declining liquidity, or share dilution), neither operating efficiency signal passes.

Earnings Quality Cash-Backed
8.07x

For every $1 of reported earnings, elf Beauty generates $8.07 in operating cash flow ($212.5M OCF vs $26.3M net income). This indicates profits are well-supported by actual cash generation, not accounting adjustments.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue
$479.4M
YoY+35.5%
QoQ+6.7%
5Y CAGR+37.6%
10Y CAGR+26.9%

elf Beauty generated $479.4M in revenue in Q1 2027. This represents an increase of 35.5% from the same quarter a year earlier. Against the prior quarter it is up 6.7%.

EBITDA
$128.5M
YoY+107.7%

elf Beauty's EBITDA was $128.5M in Q1 2027, measuring earnings before interest, taxes, depreciation, and amortization. This represents an increase of 107.7% from the same quarter a year earlier.

Net Income
$66.6M
YoY+99.9%
QoQ+234.9%
5Y CAGR+51.8%

elf Beauty reported $66.6M in net income in Q1 2027. This represents an increase of 99.9% from the same quarter a year earlier. Against the prior quarter it is up 234.9%.

EPS (Diluted)
$1.12
YoY+93.1%
QoQ+236.6%
5Y CAGR+49.5%

elf Beauty earned $1.12 per diluted share (EPS) in Q1 2027. This represents an increase of 93.1% from the same quarter a year earlier. Against the prior quarter it is up 236.6%.

Cash & Balance Sheet

Free Cash Flow
$110.2M
YoY+447.4%
QoQ+9.6%
5Y CAGR+84.5%

elf Beauty generated $110.2M in free cash flow in Q1 2027, representing cash available after capex. This represents an increase of 447.4% from the same quarter a year earlier. Against the prior quarter it is up 9.6%.

Cash & Debt
$344.2M
YoY+102.5%
QoQ+18.8%
5Y CAGR+40.3%
10Y CAGR+57.1%

elf Beauty held $344.2M in cash against $802.0M in long-term debt as of Q1 2027.

Shares Outstanding
59M
YoY+4.0%
QoQ-0.7%
5Y CAGR+2.6%

elf Beauty had 59M shares outstanding in Q1 2027. This represents an increase of 4.0% from the same quarter a year earlier. Against the prior quarter it is down 0.7%.

Dividends Per Share

Not reported for Q1 2027.

Margins & Returns

Gross Margin
83.2%
YoY+14.1pp
QoQ+10.5pp
5Y CAGR+19.4pp
10Y CAGR+26.3pp

elf Beauty's gross margin was 83.2% in Q1 2027, indicating the percentage of revenue retained after direct costs. This is up 14.1 percentage points from the same quarter a year earlier. Against the prior quarter it is up 10.5 percentage points.

Operating Margin
21.4%
YoY+7.6pp

elf Beauty's operating margin was 21.4% in Q1 2027, reflecting core business profitability. This is up 7.6 percentage points from the same quarter a year earlier.

Net Margin
13.9%
YoY+4.5pp
QoQ+24.9pp
5Y CAGR+5.4pp
10Y CAGR+20.0pp

elf Beauty's net profit margin was 13.9% in Q1 2027, showing the share of revenue converted to profit. This is up 4.5 percentage points from the same quarter a year earlier. Against the prior quarter it is up 24.9 percentage points.

Return on Equity
5.7%
YoY+1.6pp
QoQ+10.1pp
5Y CAGR+2.8pp

elf Beauty's ROE was 5.7% in Q1 2027, measuring profit generated per dollar of shareholder equity. This is up 1.6 percentage points from the same quarter a year earlier. Against the prior quarter it is up 10.1 percentage points.

Capital Allocation

Share Buybacks
$50.0M

elf Beauty spent $50.0M on share buybacks in Q1 2027, returning capital to shareholders by reducing shares outstanding.

Capital Expenditures
$1.4M
YoY-79.8%
QoQ-24.1%
5Y CAGR-9.3%
10Y CAGR+3.8%

elf Beauty invested $1.4M in capex in Q1 2027, funding long-term assets and infrastructure. This represents a decrease of 79.8% from the same quarter a year earlier. Against the prior quarter it is down 24.1%.

R&D Spending

Not reported for Q1 2027.

ELF Income Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

ELF quarterly income statement
MetricQ1'2710-QQ4'2610-KQ3'2610-KQ2'2610-KQ1'2610-QQ4'2510-KQ3'2510-KQ2'2510-K
Revenue$479.4M+35.5%$449.3M+35.1%$489.5M+37.8%$343.9M+14.2%$353.7M+9.0%$332.6M+3.6%$355.3M+31.1%$301.1M+39.7%
Cost of Revenue$80.5M-26.3%N/A$142.0M+39.2%$105.1M+20.8%$109.2M+17.2%N/A$102.0M+29.2%$87.0M+37.8%
Gross Profit$398.8M+63.1%$326.5M+37.7%$347.5M+37.2%$238.9M+11.6%$244.5M+5.7%$237.0M+4.3%$253.3M+32.0%$214.1M+40.5%
SG&A Expenses$280.3M+43.1%N/A$280.0M+28.3%$231.1M+24.2%$195.8M+8.4%N/A$218.2M+36.3%$186.1M+65.9%
Operating Income$102.4M+110.3%N/A$67.5M+92.5%$7.7M-72.4%$48.7M-3.9%N/A$35.1M+10.2%$27.9M-30.5%
EBITDA$128.5M+107.7%N/A$89.1M+90.8%$26.0M-31.9%$61.9M+3.6%N/A$46.7M+16.8%$38.2M-18.6%
Income Tax$27.7M+55.6%N/A$14.5M+60.6%-$7.0M-178.2%$17.8M+5577.8%N/A$9.0M+155.6%$8.9M+38.0%
Net Income$66.6M+99.9%-$49.4M-274.7%$39.4M+128.1%$3.0M-84.2%$33.3M-30.0%$28.3M+94.5%$17.3M-35.8%$19.0M-42.8%
EPS (Basic)$1.13+91.5%-$0.84-268.0%$0.66+112.9%$0.05-85.3%$0.59-30.6%$0.50+92.3%$0.31-36.7%$0.34-44.3%
EPS (Diluted)$1.12+93.1%-$0.82-267.3%$0.65+116.7%$0.05-84.8%$0.58-28.4%$0.49+96.0%$0.30-34.8%$0.33-43.1%
Diluted Shares (Avg)60M+3.6%N/A60M+3.1%60M+1.9%58M-1.5%N/A58M+0.6%58M+1.8%

Not reported in any period shown, so not listed: R&D Expenses, Interest Expense.

ELF Balance Sheet

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

ELF quarterly balance sheet
MetricQ1'2710-QQ4'2610-KQ3'2610-KQ2'2610-KQ1'2610-QQ4'2510-KQ3'2510-KQ2'2510-K
Total Assets$2.5B+87.1%$2.4B+91.8%$2.3B+83.7%$2.3B+87.4%$1.3B+9.1%$1.2B+10.5%$1.3B+14.1%$1.2B+65.6%
Current Assets$859.8M+42.7%$789.4M+46.0%$701.6M+25.5%$707.2M+27.7%$602.5M+13.6%$540.6M+13.3%$559.1M+22.9%$554.0M+27.2%
Cash & Equivalents$344.2M+102.5%$289.7M+94.8%$196.8M+166.5%$194.4M+100.9%$170.0M+55.9%$148.7M+37.4%$73.8M+1.6%$96.8M-42.3%
Short-Term Investments$0$0$0$0$0$0$0$0
Inventory$246.8M+44.9%$220.2M+17.7%$220.6M+2.7%$247.4M+3.6%$170.4M-14.6%$187.2M-2.3%$214.8M+5.0%$238.8M+62.2%
Accounts Receivable$174.5M+0.7%$174.6M+38.6%$190.3M+1.4%$154.7M+5.5%$173.4M+11.3%$126.0M+1.8%$187.7M+55.1%$146.6M+69.1%
Long-Term Investments$0$0$0$0$0$0$0$0
Goodwill$853.5M+150.6%$853.5M+150.6%$852.8M+150.4%$851.8M+150.1%$340.6M0.0%$340.6M0.0%$340.6M+0.1%$340.6M+98.5%
Total Liabilities$1.3B+153.3%$1.3B+159.3%$1.2B+133.6%$1.2B+131.6%$510.0M+1.8%$487.3M+0.1%$497.4M+0.7%$509.3M+121.0%
Current Liabilities$337.7M+82.8%$336.2M+89.9%$254.3M-13.5%$261.9M-15.8%$184.7M-38.4%$177.1M-40.8%$293.9M-3.0%$310.9M+104.0%
Non-Current Liabilities$954.1M+193.3%$927.5M+198.9%$907.6M+345.9%$917.9M+362.6%$325.3M+61.5%$310.3M+65.4%$203.5M+6.5%$198.4M+153.9%
Long-Term Debt$802.0M+212.5%$809.3M+215.3%$816.7M+430.1%$831.6M+430.8%$256.7M+61.2%$256.7M+58.6%$154.1M-6.3%$156.6M+171.3%
Total Equity$1.2B+45.2%$1.1B+48.6%$1.2B+51.4%$1.1B+56.5%$804.9M+14.4%$760.9M+18.4%$767.4M+24.9%$727.7M+40.9%
Retained Earnings-$89.3M+40.0%-$155.9M+14.4%-$106.6M+49.4%-$145.9M+35.9%-$148.9M+39.6%-$182.2M+38.1%-$210.5M+31.8%-$227.8M+32.2%

ELF Cash Flow Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

ELF quarterly cash flow statement
MetricQ1'2710-QQ4'2610-KQ3'2610-KQ2'2610-KQ1'2610-QQ4'2510-KQ3'2510-KQ2'2510-K
Operating Cash Flow$111.7M+310.0%$102.5M-24.7%$59.4M+503.9%$23.4M+109.7%$27.2M+2025.9%$136.1M+267.7%-$14.7M+14.1%$11.2M-60.0%
Depreciation & Amortization$26.1M+97.9%$26.3M+99.2%$21.6M+85.8%$18.3M+78.5%$13.2M+45.6%$13.2M+35.9%$11.6M+42.6%$10.2M+53.5%
Stock-Based Compensation$19.7M+99.4%N/A$29.9M+33.7%$29.5M+36.2%$9.9M-23.9%N/A$22.3M+102.3%$21.6M+93.0%
Capital Expenditures$1.4M-79.8%$1.9M-83.0%$6.6M+31.0%$6.8M+322.0%$7.1M+802.7%$11.1M+313.4%$5.1M+11.8%$1.6M+91.2%
Free Cash Flow$110.2M+447.4%$100.6M-19.6%$52.8M+367.1%$16.6M+73.6%$20.1M+3968.3%$125.0M+264.1%-$19.8M+8.7%$9.5M-64.7%
Investing Cash Flow-$1.7M+77.9%-$2.3M+79.8%-$7.9M-51.6%-$587.5M-36095.4%-$7.6M-760.0%-$11.4M-206.7%-$5.2M+98.1%-$1.6M-91.2%
Financing Cash Flow-$55.5M-45934.7%-$7.0M+86.0%-$54.0M-2243.9%$594.8M+2757.1%$121K-70.3%-$50.2M-47231.1%-$2.3M-101.1%-$22.4M-1108.0%
Share Buybacks$50.0M$0-100.0%$50.0M$0$0$50.0M$0N/A

Not reported in any period shown, so not listed: Dividends Paid.

ELF Financial Ratios

Margins and returns are percentages; the remaining ratios are unitless multiples. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

ELF quarterly financial ratios
MetricQ1'2710-QQ4'2610-KQ3'2610-KQ2'2610-KQ1'2610-QQ4'2510-KQ3'2510-KQ2'2510-K
Gross Margin83.2%+14.1pp72.7%+1.4pp71.0%-0.3pp69.5%-1.6pp69.1%-2.1pp71.3%+0.5pp71.3%+0.4pp71.1%+0.4pp
Operating Margin21.4%+7.6ppN/A13.8%+3.9pp2.2%-7.0pp13.8%-1.9ppN/A9.9%-1.9pp9.3%-9.4pp
Net Margin13.9%+4.5pp-11.0%-19.5pp8.0%+3.2pp0.9%-5.5pp9.4%-5.2pp8.5%+4.0pp4.9%-5.1pp6.3%-9.1pp
Return on Equity5.7%+1.6pp-4.4%-8.1pp3.4%+1.1pp0.3%-2.4pp4.1%-2.6pp3.7%+1.5pp2.3%-2.1pp2.6%-3.8pp
Return on Assets2.7%+0.2pp-2.1%-4.3pp1.7%+0.3pp0.1%-1.4pp2.5%-1.4pp2.3%+1.0pp1.4%-1.1pp1.5%-2.9pp
Current Ratio2.55-0.7x2.35-0.7x2.76+0.9x2.70+0.9x3.26+1.5x3.05+1.5x1.90+0.4x1.78-1.1x
Debt-to-Equity0.69+0.4x0.72+0.4x0.70+0.5x0.73+0.5x0.32+0.1x0.34+0.1x0.20-0.1x0.22+0.1x
Asset Turnover0.19-0.1x0.19-0.1x0.21-0.1x0.15-0.1x0.270.0x0.270.0x0.280.0x0.240.0x
FCF Margin23.0%+17.3pp22.4%-15.2pp10.8%+16.3pp4.8%+1.7pp5.7%+5.5pp37.6%+26.9pp-5.6%+2.4pp3.2%-9.4pp

Similar Companies

Newest fiscal year on record for each company. The health score is the peer-relative Financial Health Score for that year; a dash means no score is published for it.

Company Fiscal year Revenue Net income Net margin Market cap Health score
elf Beauty ELF FY2026 $1.6B $26.3M 1.6% $6.2B 61/100
Coty Inc COTY FY2026 $5.8B -$604.8M -10.4% $2.5B 29/100
Interparfums Inc IPAR FY2025 $1.5B $208.0M 14.0% $3.8B 77/100
Newell Brands NWL FY2025 $7.2B -$285.0M -4.0% $2.7B 25/100
Hims & Hers Health Inc HIMS FY2025 $2.3B $128.4M 5.5% $6.9B 51/100
Estee Lauder Companies EL FY2026 $15.0B $182.0M 1.2% $37.0B 37/100

Frequently Asked Questions

What is elf Beauty's annual revenue?

elf Beauty (ELF) reported $1.6B in total revenue for fiscal year 2026. This represents a 24.6% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

How fast is elf Beauty's revenue growing?

elf Beauty (ELF) revenue grew by 24.6% year-over-year, from $1.3B to $1.6B in fiscal year 2026.

Is elf Beauty profitable?

Yes, elf Beauty (ELF) reported a net income of $26.3M in fiscal year 2026, with a net profit margin of 1.6%.

elf Beauty (ELF) reported diluted earnings per share of $0.44 for fiscal year 2026. This represents a -77.1% change compared to the previous fiscal year. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

elf Beauty (ELF) had EBITDA of $153.0M in fiscal year 2026, measuring earnings before interest, taxes, depreciation, and amortization.

As of fiscal year 2026, elf Beauty (ELF) had $289.7M in cash and equivalents against $809.3M in long-term debt.

elf Beauty (ELF) had a gross margin of 70.7% in fiscal year 2026, indicating the percentage of revenue retained after direct costs of goods sold.

elf Beauty (ELF) had an operating margin of 4.5% in fiscal year 2026, reflecting the profitability of core business operations before interest and taxes.

elf Beauty (ELF) had a net profit margin of 1.6% in fiscal year 2026, representing the share of revenue converted into profit after all expenses.

elf Beauty (ELF) has a return on equity of 2.3% for fiscal year 2026, measuring how efficiently the company generates profit from shareholder equity.

elf Beauty (ELF) generated $190.1M in free cash flow during fiscal year 2026. This represents a 64.8% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.

elf Beauty (ELF) generated $212.5M in operating cash flow during fiscal year 2026, representing cash generated from core business activities.

elf Beauty (ELF) had $2.4B in total assets as of fiscal year 2026, including both current and long-term assets.

elf Beauty (ELF) invested $22.4M in capital expenditures during fiscal year 2026, funding long-term assets and infrastructure.

Yes, elf Beauty (ELF) spent $50.0M on share buybacks during fiscal year 2026, returning capital to shareholders by reducing shares outstanding.

elf Beauty (ELF) had 59M shares outstanding as of fiscal year 2026.

elf Beauty (ELF) had a current ratio of 2.35 as of fiscal year 2026, which is generally considered healthy.

elf Beauty (ELF) had a debt-to-equity ratio of 0.72 as of fiscal year 2026, measuring the company's financial leverage by comparing total debt to shareholder equity.

elf Beauty (ELF) had a return on assets of 1.1% for fiscal year 2026, measuring how efficiently the company uses its assets to generate profit.

elf Beauty (ELF) trades at 104x earnings, its market capitalization divided by net income of $59.6M net income, trailing 12 months to June 30, 2026. The market capitalization is $6.2B as of Sep 2, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.

elf Beauty (ELF) trades at 3.5x sales, its market capitalization divided by revenue of $1.8B revenue, trailing 12 months to June 30, 2026. The market capitalization is $6.2B as of Sep 2, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.

elf Beauty (ELF) has an Altman Z-Score of 3.88, placing it in the Safe Zone (low bankruptcy risk). The Z-Score combines five financial ratios (working capital, retained earnings, EBIT, market capitalization, and revenue relative to total assets) to predict the likelihood of bankruptcy. Scores above 2.99 indicate financial safety while scores below 1.81 suggest financial distress. Learn more in our complete guide to financial health indicators.

elf Beauty (ELF) has a Piotroski F-Score of 3 out of 9, indicating weak financial health. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

elf Beauty (ELF) has an earnings quality ratio of 8.07x, considered cash-backed (high quality). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

elf Beauty (ELF) scores 61 out of 100 on our Financial Health Score, indicating moderate standing within its operating companies peer group. The score is a 0-100 composite of six dimensions (Profitability, Growth, Leverage, Liquidity, Cash Flow, Returns), each ranked as a percentile relative to companies in the same scoring family (banks against banks, REITs against REITs, and so on) rather than across all industries. It rates the quality of the business, not whether the stock is fairly priced, and is not financial advice. Learn more in our complete guide to financial health indicators.

Back to top